Advanced Implantable Medical Device Delivery Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept envisions a next-generation implantable medical device delivery system that leverages cutting-edge technologies such as biodegradable materials, nanotechnology, micro-robotics, and artificial intelligence to revolutionize the field of medical devices.
Background and Problem Solved
The original patent disclosed a delivery system for implantable medical devices, but it had limitations in terms of flexibility, precision, and real-time analysis. The new inventive concept addresses these limitations by introducing innovative components and methods that provide enhanced performance, safety, and patient outcomes.
Detailed Description of the Inventive Concept
The advanced delivery system comprises a biodegradable sheath with a programmable degradation rate, allowing for controlled and targeted release of the implantable medical device. The system also features an elongate member with a self-adjusting diameter, enabling seamless navigation through complex vasculature. Furthermore, the nanotechnology-enhanced tip provides real-time tissue analysis, ensuring accurate and safe deployment of the device. In addition, the system may utilize micro-robotic assistants, swarm of micro-devices, and AI-powered diagnostic units to facilitate the delivery process.
Novelty and Inventive Step
The new claims introduce a paradigm shift in implantable medical device delivery by incorporating biodegradable materials, nanotechnology, micro-robotics, and artificial intelligence. These advancements provide a significant improvement over the original patent, offering enhanced precision, safety, and patient outcomes.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include variations in the biodegradable sheath material, the design of the self-adjusting elongate member, and the type of nanotechnology used in the tip. Additionally, the system could be adapted for use in different medical specialties, such as cardiovascular or neurovascular interventions.
Potential Commercial Applications and Market
The advanced implantable medical device delivery system has the potential to disrupt the medical device industry, offering a new standard of care for patients. The target market includes medical device manufacturers, hospitals, and healthcare providers, with potential applications in various medical specialties.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/0095 |
| A | A61 | A61B50/30 |
| A | A61 | A61F2/2412 |
| A | A61 | A61F2/2436 |
| A | A61 | A61F2/24 |
| A | A61 | A61F2/46 |
| A | A61 | A61F2/9526 |
| A | A61 | A61L2300/404 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Engineering, specifically implantable device delivery systems, involving advanced interventional medical technologies with expertise in biomechanical design, material science, and minimally invasive surgical techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, 5-7 years professional experience in medical device design, familiar with interventional cardiology and vascular access technologies, skilled in materials engineering and device miniaturization
Obviousness Rationale
A PHOSITA would recognize that the PTD's proposed variations represent predictable technological extensions of the source patent's fundamental delivery system design. The core mechanical and functional principles remain consistent, with incremental improvements in materials, navigation, and diagnostic capabilities that are well-established design optimization strategies in medical device engineering. The proposed nanotechnology, micro-robotic, and AI enhancements represent natural technological progressions consistent with contemporary medical device research trends.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,404 |
|---|---|
| Title | Storage devices, loading devices, delivery systems, kits, and associated methods |
| Assignee(s) | Cook Medical Technologies LLC, Muffin Incorporated |